Skip to content
Try Mental Wellness – Lifestyle
Author:
mAbxience
Fresenius completes acquisition of mAbxience, creating a stronger platform for future portfolio expansion
October 1, 2026
mAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide
September 18, 2026